Pasithea Therapeutics KTTA
NASDAQ KTTA
$0.50 +0.01 (+2.17%)
As of: Oct 2, 2026 · 1:28 PM EDT

Pasithea Therapeutics (KTTA) Non Operating Income (2021 - 2026)

Updated

Pasithea Therapeutics' Non Operating Income was $439,430 in Q2 2026, up 363.8% from $94,742 a year earlier but down 78.1% from the prior quarter.

Analysis

Pasithea Therapeutics (KTTA) Non Operating Income (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Pasithea Therapeutics' Non Operating Income was $2.66 million through Jun 30, 2026, up 793.1% year-over-year; for FY2025, it came in at $429,612, up 24.4% from FY2024.

  • Non Operating Income shows a four-year compound annual growth rate of -34.5% (FY2021 to FY2025).
  • In earlier years, Non Operating Income was $345,378 in FY2024 (-26.8%), $471,613 in FY2023 and $2.33 million in FY2021.
  • Quarterly Non Operating Income has moved between -$335,317 (Q3 2022) and $2.59 million (Q4 2021) over five years.
  • Compared with a year earlier, Non Operating Income was higher in three of the last six quarters, with growth averaging 49.8%.
  • The best year-over-year quarter for Non Operating Income over five years was Q2 2026 (growth of 363.8%); the worst was Q3 2024 (a decline of 97.3%).
  • Per Business Quant data, KTTA's Non Operating Income in the three quarters before Q2 2026 was $2.01 million (Q1 2026), $145,294 (Q4 2025) and $72,635 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -73.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 387.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Pasithea Therapeutics 16.37 Mn 16.37 Mn - 439,430.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 439,430.00
Mar 31, 2026 2.01 Mn
Dec 31, 2025 145,294.00
Sep 30, 2025 72,635.00
Jun 30, 2025 94,742.00
Mar 31, 2025 116,941.00
Dec 31, 2024 81,889.00
Sep 30, 2024 4,770.00
Jun 30, 2024 78,785.00
Mar 31, 2024 179,934.00
Dec 31, 2023 117,518.00
Sep 30, 2023 176,736.00
Jun 30, 2023 230,617.00
Mar 31, 2023 -53,258.00
Sep 30, 2022 -335,317.00
Jun 30, 2022 421,700.00
Mar 31, 2022 830,297.00
Dec 31, 2021 2.59 Mn
Sep 30, 2021 -252,508.00
API Access

Pasithea Therapeutics Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=KTTA&period=max&api_key=YOUR_API_KEY